Redeye updates its estimates following Freemelt’s Q4 report, which came in above our expectations in terms of sales. The company has started 2025 on a strong note, securing several important orders. Redeye argues that 2025 is a crucial year for the company, and we have high expectations for it to accelerate its business in all aspects compared to previous years.

Read more and download the Research Update.
 
Follow companies at Redeye to receive the latest equity research within Life Science and Technology.
 
This is a press release from Redeye - Research Powered Investment Banking. www.redeye.se/